Further structural analysis of OspC3 and Nlef virulence facors, capable of inactivating human caspase-4 activtiy, would be informative for the design of small molecule inhibitors for the treatment of inflammatory disorders associated with elevated caspase activity, such as IBD. Here, CASP4 is linked to inflammatory bowel disease.